Gastrointestinal

The Pharmacy Times® Gastrointestinal resource center provides news and articles centered around the FDA approved drugs in gastroenterology, as well as links to condition-specific resources, and videos and other content.

What can we help you find?
[[thumbnail_alt_text]]
Pharmacists can, and should, play an important role in counseling patients before they travel anywhere about what to do in the event of a GI illness while vacationing.
[[thumbnail_alt_text]]
Why is this healthy young man getting frequent food poisoning?
[[thumbnail_alt_text]]
Travel health services involves a lot more than vaccinations, said Sheri Stensland, PharmD, in a session at McKesson ideaShare.
[[thumbnail_alt_text]]
Parvus Therapeutics and Genentech have entered into a worldwide collaboration and licensing agreement for the development, manufacturing, and commercialization of treatments for inflammatory bowel disease, autoimmune liver diseases, and celiac disease using nanomedicines (Navacim) developed by Parvus.
[[thumbnail_alt_text]]
If approved, Gimoti would be the first non-oral drug treatment for symptoms associated with acute and recurrent diabetic gastroparesis in adult women and would represent the first significant advancement in the treatment of gastroparesis in 40 years.
[[thumbnail_alt_text]]
The drug is indicated for those patients who were previously treated with at least 2 prior lines of chemotherapy that included a fluoropyrimidine, a platinum, either a taxane or irinotecan, and if appropriate, HER2/neu-targeted therapy.
[[thumbnail_alt_text]]
Rifamycin's effectiveness was shown in a randomized, placebo-controlled clinical trial during which the drug significantly reduced symptoms of travelers’ diarrhea in adults afflicted with the condition in Guatemala and Mexico. 
[[thumbnail_alt_text]]
Opioids are associated with various adverse effects, including constipation, nausea, respiratory depression, sedation, and vomiting.
[[thumbnail_alt_text]]
Officials with the FDA have approved eravacycline (XERAVA, Tetraphase Pharmaceuticals), a fluorocycline antibacterial within the tetracycline class of antibacterial drugs, for the treatment of complicated intra-abdominal infections (cIAI) in patients aged 18 years and older.
[[thumbnail_alt_text]]
The CDC and FDA are currently investigating a multistate outbreak of Cyclospora infections (cyclosporiasis) linked to McDonald’s salads.
[[thumbnail_alt_text]]
Irritable bowel syndrome is a chronic, relapsing functional gastrointestinal disorder.